Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gillis

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Cancer Research|February 15, 1990
Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patientsJ Treisman, C M Higuchi, J A Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligandH Mitsui, T Furitsu, A M Dvorak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 1992
The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophilsM Columbo, E M Horowitz, L M Botana, et al.
The New England Journal of Medicine|June 20, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancerJ Nemunaitis, S N Rabinowe, J W Singer, et al.
Molecular Immunology|September 1, 1988
Bovine GM-CSF: molecular cloning and biological activity of the recombinant proteinC R Maliszewski, M A Schoenborn, D P Cerretti, et al.
Behring Institute Mitteilungen|August 1, 1988
Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantationB R Blazar, M B Widmer, J H Kersey, et al.
Journal of Cutaneous Medicine and Surgery|September 20, 2021
A Review of Oral Therapies for the Treatment of Skin HyperpigmentationSerena J E Shimshak, Leila M Tolaymat, Claire B Haga, et al.
The Journal of Molecular and Cellular Immunology : JMCI|January 1, 1988
Differential induction of class II gene expression in murine pre-B-cell lines by B-cell stimulatory factor-1 and by antibodies to B-cell surface antigensB S Polla, J Ohara, W E Paul, et al.
The New England Journal of Medicine|December 22, 1988
Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, S Buescher, H E Broxmeyer, et al.
Science (New York, N.Y.)|March 13, 1992
The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptorD P Gearing, M R Comeau, D J Friend, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Cancer Research|February 15, 1990
Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patientsJ Treisman, C M Higuchi, J A Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligandH Mitsui, T Furitsu, A M Dvorak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 1992
The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophilsM Columbo, E M Horowitz, L M Botana, et al.
The New England Journal of Medicine|June 20, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancerJ Nemunaitis, S N Rabinowe, J W Singer, et al.
Molecular Immunology|September 1, 1988
Bovine GM-CSF: molecular cloning and biological activity of the recombinant proteinC R Maliszewski, M A Schoenborn, D P Cerretti, et al.
Behring Institute Mitteilungen|August 1, 1988
Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantationB R Blazar, M B Widmer, J H Kersey, et al.
Journal of Cutaneous Medicine and Surgery|September 20, 2021
A Review of Oral Therapies for the Treatment of Skin HyperpigmentationSerena J E Shimshak, Leila M Tolaymat, Claire B Haga, et al.
The Journal of Molecular and Cellular Immunology : JMCI|January 1, 1988
Differential induction of class II gene expression in murine pre-B-cell lines by B-cell stimulatory factor-1 and by antibodies to B-cell surface antigensB S Polla, J Ohara, W E Paul, et al.
The New England Journal of Medicine|December 22, 1988
Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, S Buescher, H E Broxmeyer, et al.
Science (New York, N.Y.)|March 13, 1992
The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptorD P Gearing, M R Comeau, D J Friend, et al.
Pageof 27